Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium.
Questions are emerging concerning the long-term consequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, as a possible increase in type 1 diabetes. This study aims to describe the prevalence of anti-SARS-CoV-2 antibodies in children developing type 1 diabetes during this pandemic in Belgium. ; SCOPUS: ar.j ; info:eu-repo/semantics/published
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Schlagwörter: | Sciences bio-médicales et agricoles / Adolescent / Antibodies / Viral -- blood / Belgium -- epidemiology / COVID-19 -- epidemiology / Child / Preschool / Diabetes Mellitus / Type 1 -- immunology / Female / Humans / Male / SARS-CoV-2 -- immunology / SARS-CoV-2 antibodies / serology / type 1 diabetes |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28550139 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/337889 |